Sen. Markwayne Mullin Purchases Shares of IQVIA Holdings Inc. (NYSE:IQV)

Posted by Defense World Staff on Jan 18th, 2026

Senator Markwayne Mullin (R-Oklahoma) recently bought shares of IQVIA Holdings Inc. (NYSE:IQV). In a filing disclosed on January 16th, the Senator disclosed that they had bought between $15,001 and $50,000 in IQVIA stock on December 29th.

Senator Markwayne Mullin also recently made the following trade(s):

Purchased $15,001 – $50,000 in shares of Deere & Company (NYSE:DE) on 12/29/2025.
Purchased $15,001 – $50,000 in shares of Hilton Worldwide (NYSE:HLT) on 12/29/2025.
Purchased $15,001 – $50,000 in shares of RTX (NYSE:RTX) on 12/29/2025.
Purchased $15,001 – $50,000 in shares of CocaCola (NYSE:KO) on 12/29/2025.
Purchased $15,001 – $50,000 in shares of Elevance Health (NYSE:ELV) on 12/29/2025.
Purchased $1,001 – $15,000 in shares of American Express (NYSE:AXP) on 12/29/2025.
Purchased $100,001 – $250,000 in shares of Amazon.com (NASDAQ:AMZN) on 12/29/2025.
Purchased $50,001 – $100,000 in shares of JPMorgan Chase & Co. (NYSE:JPM) on 12/29/2025.
Purchased $15,001 – $50,000 in shares of The Goldman Sachs Group (NYSE:GS) on 12/29/2025.
Purchased $15,001 – $50,000 in shares of Boston Scientific (NYSE:BSX) on 12/29/2025.

IQVIA Trading Down 1.3%

NYSE IQV opened at $238.03 on Friday. The company has a debt-to-equity ratio of 2.03, a current ratio of 0.70 and a quick ratio of 0.70. The stock has a market capitalization of $40.54 billion, a P/E ratio of 32.65, a PEG ratio of 2.42 and a beta of 1.36. The firm’s 50-day moving average is $227.30 and its two-hundred day moving average is $203.34. IQVIA Holdings Inc. has a 12 month low of $134.65 and a 12 month high of $247.04.

IQVIA (NYSE:IQV – Get Free Report) last issued its quarterly earnings data on Tuesday, October 28th. The medical research company reported $3.00 EPS for the quarter, topping the consensus estimate of $2.98 by $0.02. The firm had revenue of $4.10 billion for the quarter, compared to analyst estimates of $4.07 billion. IQVIA had a net margin of 8.07% and a return on equity of 30.70%. The business’s revenue for the quarter was up 5.2% compared to the same quarter last year. During the same period in the prior year, the business posted $2.84 EPS. IQVIA has set its FY 2025 guidance at 11.850-11.950 EPS. On average, sell-side analysts anticipate that IQVIA Holdings Inc. will post 10.84 earnings per share for the current year.

Institutional Trading of IQVIA

Several hedge funds have recently added to or reduced their stakes in the company. Claret Asset Management Corp raised its holdings in shares of IQVIA by 1.1% in the 3rd quarter. Claret Asset Management Corp now owns 4,527 shares of the medical research company’s stock valued at $860,000 after purchasing an additional 49 shares in the last quarter. Versant Capital Management Inc raised its stake in IQVIA by 6.3% in the third quarter. Versant Capital Management Inc now owns 899 shares of the medical research company’s stock valued at $171,000 after buying an additional 53 shares in the last quarter. Leonard Rickey Investment Advisors P.L.L.C. lifted its holdings in IQVIA by 3.3% during the 4th quarter. Leonard Rickey Investment Advisors P.L.L.C. now owns 1,814 shares of the medical research company’s stock worth $409,000 after buying an additional 58 shares during the last quarter. Brookstone Capital Management boosted its position in shares of IQVIA by 2.2% during the 4th quarter. Brookstone Capital Management now owns 2,931 shares of the medical research company’s stock worth $661,000 after acquiring an additional 63 shares in the last quarter. Finally, Private Advisor Group LLC increased its holdings in shares of IQVIA by 1.0% in the 3rd quarter. Private Advisor Group LLC now owns 6,122 shares of the medical research company’s stock valued at $1,163,000 after acquiring an additional 63 shares during the last quarter. Institutional investors and hedge funds own 89.62% of the company’s stock.

Insiders Place Their Bets

In related news, insider Eric Sherbet sold 4,000 shares of the company’s stock in a transaction that occurred on Wednesday, October 29th. The stock was sold at an average price of $219.70, for a total value of $878,800.00. Following the completion of the transaction, the insider directly owned 27,108 shares of the company’s stock, valued at $5,955,627.60. This represents a 12.86% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. 1.60% of the stock is currently owned by insiders.

Analyst Ratings Changes

IQV has been the subject of several research analyst reports. Morgan Stanley raised their price target on IQVIA from $250.00 to $265.00 and gave the stock an “overweight” rating in a research report on Monday, December 1st. HSBC upgraded IQVIA from a “hold” rating to a “buy” rating and raised their target price for the company from $195.00 to $235.00 in a report on Thursday, October 9th. Mizuho set a $266.00 price target on shares of IQVIA in a research note on Friday, January 9th. Truist Financial increased their price target on shares of IQVIA from $265.00 to $290.00 and gave the stock a “buy” rating in a research report on Thursday, January 8th. Finally, Robert W. Baird set a $258.00 price objective on shares of IQVIA and gave the company an “outperform” rating in a report on Wednesday, October 29th. Two investment analysts have rated the stock with a Strong Buy rating, thirteen have given a Buy rating and six have assigned a Hold rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $249.19.

Read Our Latest Analysis on IQV

About Senator Mullin

Markwayne Mullin (Republican Party) is a member of the U.S. Senate from Oklahoma. He assumed office on January 11, 2023. His current term ends on January 3, 2027. Mullin (Republican Party) ran in a special election to the U.S. Senate to represent Oklahoma. He won in the special general election on November 8, 2022. Mullin is a member of the Cherokee Nation and one of four Native American members of the 116th Congress. At the age of 20, Mullin took over his father’s plumbing business. He is also a former professional mixed martial artist. Markwayne Mullin graduated from Stilwell High School. Mullin earned an associate degree in construction technology from Oklahoma State University Institute of Technology. His career experience includes owning and founding multiple businesses.

IQVIA Company Profile

(Get Free Report)

IQVIA (NYSE: IQV) is a global provider of advanced analytics, technology solutions and contract research services to the life sciences industry. The company combines clinical research capabilities with large-scale health data and analytics to support drug development, regulatory reporting, commercial strategy and real‑world evidence generation. IQVIA traces its current form to the combination of Quintiles and IMS Health announced in 2016 and subsequently rebranded as IQVIA, bringing together long-established clinical research operations and extensive healthcare information assets.

IQVIA’s principal activities include outsourced clinical development services (acting as a contract research organization for phases I–IV), real‑world evidence and observational research, regulatory and safety services, and a suite of technology platforms that enable data integration, analytics and operational management.